Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation

American Journal of Cardiology

Volumn 91, Issue 1, 2003, Pages 81-83

  Zimetbaum, Peter ^{a,b,c,d,e,f,g}   Ho, Kalon K L ^a,b,c,d,e,f   Olshansky, Brian ^a,b,c,d,e,f   Hadjis, Thomas ^a,b,c,d,e,f   Lemery, Robert ^a,b,c,d,e,f   Friedman, Paul A ^a,b,c,d,e,f   Cannom, David S ^a,b,c,d,e,f   Chen, Xiao Hua ^a,b,c,d,e,f   Josephson, Mark E ^a,b,c,d,e,f  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e MAYO CLINIC   (United States)

^f GOOD SAMARITAN HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANADA; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; REGISTER; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CANADA; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES;

EID: 0037219128     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03004-7     Document Type: Article

References (6)

1. Fuster V, Ryden LE, Asinger R, Cannom D, Crijns H, Frye R, Halperin J, Kay G, Klein W, Levy S, McNamara R, Prystowsky E, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: Executive Summary. J Am Coll Cardiol 2001:38:1232-1265.
2. Stafford R., Robson D., Misra B., Ruskin J., Singer D. Rate control and sinus rhythm maintenance in atrial fibrillation. Arch Intern Med. 158:1998;2144-2148.
3. Humphries K., Kerr C., Connolly S., Klein G., Boone J. New-Onset atrial fibrillation sex differences in presentation, treatment and outcome . Circulation. 103:2001;2365-2370.
4. Roy D., Talajic M., Dorian P., Connolly S., Eisenber M.J. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 342:2000;913-920.
5. Levy S., Maarek M., Coumel P., Guize L., Lekieffre J. Characterization of different subsets of atrial fibrillation in general practice in France The ALFA Study . Circulation. 99:1999;3028-3035.
6. Brodsky M., Chun J., Podrid P., Douban S., Allen B., Cygan R. Regional Attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. Arch intern Med. 156:1996;2553-2562.